The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-3-(4-(trifluoromethyl)phenyl sulfonyl)propanamide ID: ALA4541556
PubChem CID: 155551497
Max Phase: Preclinical
Molecular Formula: C18H14F6N2O6S
Molecular Weight: 500.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(O)(CS(=O)(=O)c1ccc(C(F)(F)F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1
Standard InChI: InChI=1S/C18H14F6N2O6S/c1-16(28,9-33(31,32)12-5-2-10(3-6-12)17(19,20)21)15(27)25-11-4-7-14(26(29)30)13(8-11)18(22,23)24/h2-8,28H,9H2,1H3,(H,25,27)
Standard InChI Key: MGXFOLLDXHFBKO-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 34 0 0 0 0 0 0 0 0999 V2000
16.0127 -20.8545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6044 -20.1419 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.1915 -20.8518 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1821 -18.9085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1810 -19.7360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8958 -20.1488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6123 -19.7355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6094 -18.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8941 -18.4958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4662 -20.1479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7521 -19.7347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0373 -20.1468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7527 -18.9098 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3231 -19.7336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7113 -20.7590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4696 -20.7590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8941 -19.7325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8944 -18.9148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1849 -18.5054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4743 -18.9159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4775 -19.7399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1876 -20.1455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3274 -20.1469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3287 -20.9719 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.0412 -19.7332 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.0378 -20.5586 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
21.3245 -18.4883 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.3214 -17.6633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0405 -18.8981 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.7590 -18.5048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7573 -17.6798 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.0454 -18.9188 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.0418 -18.0919 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 4 2 0
5 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 2 1 0
12 15 1 0
12 16 1 0
2 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
7 23 1 0
23 24 1 0
23 25 1 0
23 26 1 0
27 28 2 0
27 29 1 0
8 27 1 0
20 30 1 0
30 31 1 0
30 32 1 0
30 33 1 0
M CHG 2 27 1 29 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 500.37Molecular Weight (Monoisotopic): 500.0477AlogP: 3.80#Rotatable Bonds: 6Polar Surface Area: 126.61Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.52CX Basic pKa: ┄CX LogP: 3.53CX LogD: 3.53Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.35Np Likeness Score: -1.32
References 1. Bassetto M, Ferla S, Pertusati F, Kandil S, Westwell AD, Brancale A, McGuigan C.. (2016) Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer., 118 [PMID:27131065 ] [10.1016/j.ejmech.2016.04.052 ]